The Intentional Non-Adherence Scale (INAS): Initial development and validation

John Weinman, Selina Graham, Martha Canfield, Maria Kleinstäuber, Anna I Perera, Nicola Dalbeth, Keith J Petrie

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)
578 Downloads (Pure)


Adherence continues to be a major challenge in healthcare but there is still limited understanding of all the factors which can influence adherence behaviour. The present study was designed to identify a range of factors associated with intentional non-adherence and to see if they could be formed into a psychometrically sound scale.

Patients in three different clinical groups (Hypertension (N = 175); Oncology (N = 115); Gout (N = 196)) were given the new scale together with an adherence self-report and/or biomarker measure. Other, more established measures of factors known to be associated with adherence (BMQ, PAM, BIPQ), were also completed by patients for comparative and validation purposes.

Exploratory Factor Analysis (EFA) was conducted to examine the factor structure of the new scale, and other statistical analyses were used for testing the psychometric properties of the new scale.

EFA revealed two factors, which were labelled “Resisting illness” and “Testing treatment”. Both scales were found to have good psychometric properties and explained unique variance in adherence in all three clinical groups.

This new scale shows promise in describing and explaining some relatively novel factors underlying treatment non-adherence. Further work in different patient groups and clinical contexts is needed to confirm the factor structure and predictive value of these scales.
Original languageEnglish
Pages (from-to)110-116
JournalJournal of Psychosomatic Research
Early online date21 Oct 2018
Publication statusPublished - Dec 2018


Dive into the research topics of 'The Intentional Non-Adherence Scale (INAS): Initial development and validation'. Together they form a unique fingerprint.

Cite this